The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot study of immune checkpoint inhibition in combination with radiation therapy in patients with metastatic pancreatic cancer.
 
Austin G. Duffy
No Relationships to Disclose
 
Oxana V. Makarova-Rusher
No Relationships to Disclose
 
David E Kleiner
No Relationships to Disclose
 
Christine Alewine
No Relationships to Disclose
 
William Douglas Figg
Research Funding - Astellas Pharma (Inst); Biocompatibles (Inst); Celgene (Inst); Nerviano Medical Sciences (Inst); NovaRX (Inst); Pfizer (Inst); TRACON Pharma (Inst)
 
Seth M. Steinberg
No Relationships to Disclose
 
Elliot B Levy
Stock and Other Ownership Interests - Halyard Health
 
Venkatesh P Krishnasamy
No Relationships to Disclose
 
Bradford J. Wood
No Relationships to Disclose
 
Deborah E. Citrin
No Relationships to Disclose
 
Jennifer C Jones
Patents, Royalties, Other Intellectual Property - Intellectual property relating to nanoFACS, targeted immune adjuvants in combination with cytotoxic immunotherapies, and EV subset detection filed or pending by Stanford University, DFCI, and NIH/NCI 2010-2016. No royalties received by the speaker.
Other Relationship - Beckman Coulter/NIH
 
Tim F. Greten
No Relationships to Disclose